Cidara Therapeutics develops long-acting anti-infective therapies, with lead products including rezafungin acetate for invasive fungal infections and Cloudbreak platform conjugates targeting viral ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback